February 10, 2023 06:14 AM ESTUpdated 07:49 AM
Peer Review

Bay­er, Astel­las gear up for next CEOs; Ex-AM­AG chief Scott My­ers resur­faces at Virid­i­an

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ You know how we told you last week that we’d keep our eyes peeled for where ex-Roche Phar­ma­ceu­ti­cals CEO Bill An­der­son turns up …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

The elec­tion is Tues­day. What’s at stake for the phar­ma in­dus­try?

Is there room for MASH drugs in a GLP-1 world?

'We play to win': As­traZeneca de­tails first re­sults for oral GLP-1 and broad­er obe­si­ty am­bi­tions

FDA cites Mark Cuban's drug com­pound­ing cen­ter in Dal­las with steril­i­ty, qual­i­ty con­cerns

Viking's oral weight loss drug ap­pears to have strong ef­fect in Phase 1 tri­al

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times